Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new ‌drug candidates to send into human ...

General Dynamics Corporation is rated a Buy due to multi-year upside in aerospace, ground vehicles and marine systems. Read ...

While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

Despite lots of hype, "voice AI" has so far largely been a euphemism for a request-response loop. You speak, a cloud server ...

A combination of weather events culminated in the perfect recipe for a winter storm. Here's how it happened.

Malicious Chrome extensions posing as productivity tools were found stealing session tokens, blocking security controls, and ...

By Dr. Liji Thomas, MD Large-scale UK Biobank data show that the EAT-Lancet planetary health diet is associated with lower CKD risk, with genetics, green space, and molecular signatures shaping who ...

Background Lung cancer screening is effective for people at higher risk of the disease, but there is no international ...

Accurate forecasts matter as AI-powered data centers drive rapid demand growth. Underestimating demand can strain reliability ...

Familial Hypobetalipoproteinemia (FHBL), caused by variants in the apolipoprotein B (APOB) gene, is a rare autosomal ...